Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Time for $5 graphics

Cepheid's price gouging for lifesaving test
Cepheid, it's time for $5
Tuberculosis - The world's deadliest infectious disease
Danaher! Cepheid! Don't fail this test! Drop the Price! $5 for ALL GeneXpert tests

Read, watch, share

MSF Logo
Statement
Statement |
06 May 2026

MSF Access welcomes Kris Torgeson as incoming Executive Director

MSF Staff speaks about immunisation challenges and pathways MSF
24 April 2026
Vaccines

A shot of urgency: Five key pathways to reach more people with lifesaving vaccines

Report Cover Image
Letter |
17 April 2026
Pandemic preparedness Research and development

Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement

April Newsletter cover image
Newsletter
Newsletter |
10 April 2026

Bringing people at the periphery to the centre

Report
Report |
09 April 2026
Research and development
KenyaRwandaSouth Africa

Shifting Global Health R&D Funding: Opportunities in a Changing Landscape

MSF protests at International AIDS Conference asking for price reduction for CAB-LA and LEN-LA
Press release
Press release |
30 March 2026
HIV/AIDS

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

MSF doctor Dr. Maham Khalid interacts with the mother of five-year-old Hareem and four-year-old Ahmad during a consultation at the MSF-supported Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site in Gujranwala, Punjab. Photo Credit: Gul Nayab
Feature story
Feature story |
27 March 2026
Tuberculosis

A mother’s journey: Caring for her children with drug-resistant TB

2 min
Report
Report |
26 March 2026
Antimicrobial resistance
EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury